Ketanserin and Naftopidil Enhance the Potentiating Effect of Alpha-Methyl-Serotonin on the Neurally-Induced Contraction of Human Isolated Urinary Bladder Muscle Strips

다국어 초록 (Multilingual Abstract)

Purpose: The aim of this study was to assess the potential involvement of a specific subtype of 5-hydroxytryptamine (5-HT), 5HT2 receptors in neurally-induced contractions of the human detrusor.
Methods: Contractile responses to electrical field stimulation (EFS) were examined in human isolated urinary bladder muscle strips. The potentiation of EFS-induced detrusor contraction was examined by adding cumulative concentrations of a 5-HT and 5-HT2 receptor agonist, α-methyl-serotonin (α-Me-5-HT) (1nM–100μM) in the presence or absence of a 5-HT2 antagonist, ketanserin (5-HT2A>5-HT2C) or naftopidil (5-HT2B>5-HT2A) (0.3–3μM).
Results: 5-HT and α-Me-5-HT potentiated EFS-induced contraction with a maximal effect (Emax) of 37.6% and 38.6%, respectively, and with pEC50 (negative logarithm of the concentration required for a half-maximal response to an agonist) values of 8.3 and 6.8, respectively. Neither ketanserin nor naftopidil at any concentration produced a rightward displacement of the α-Me-5-HT concentration response curve. Instead, the Emax of α-Me-5-HT increased in the presence of ketanserin at 0.3–1μM and in the presence of naftopidil at 1μM to 51% and 56%, respectively, while the Emax in the presence of vehicle alone was 36%.
The highest concentration (3μM) of either drug, however, fully reversed the enhancement.
Conclusions: The potentiating effect of α-Me-5-HT on neurally-induced contraction of human urinary bladder muscle strips was not found to be mediated via any 5-HT2 receptor subtypes. The underlying mechanism for the enhancement of the α-Me- 5-HT potentiating effect on detrusor contractility by ketanserin and naftopidil remains unknown; however, our results suggest that these drugs may be useful for treating contractile dysfunction of the detrusor, as manifested in conditions such as underactive bladder.

참고문헌 (Reference)

1 Hoyer D, "[3H]ketanserin labels 5-HT2 receptors and alpha 1-adrenoceptors in human and pig brain membranes" 335 : 226-230, 1987

2 Ramage AG., "The role of central 5-hydroxytryptamine (5-HT, serotonin)receptors in the control of micturition" 147 (147): S120-S131, 2006

3 Maes M, "The new ‘5-HT’ hypothesis of depression: cell-mediated immune activation induces indoleamine 2,3-dioxygenase, which leads to lower plasma tryptophan and an increased synthesis of detrimental tryptophan catabolites (TRYCATs), both of which contribute to the onset of depression" 35 : 702-721, 2011

4 Hørby-Petersen J, "The effects of a new serotonin receptor antagonist(ketanserin)on lower urinary tract function in patients with prostatism" 133 : 1094-1098, 1985

5 Siddiqui EJ, "The effect of serotonin and serotonin antagonists on bladder cancer cell proliferation" 97 : 634-639, 2006

6 Alexander SP, "The Concise Guide to PHARMACOLOGY 2015/16 : G protein-coupled receptors" 172 : 5744-5869, 2015

7 Jungwirth N, "Serotonin used as prognostic marker of urological tumors" 26 : 499-504, 2008

8 Sarrouilhe D, "Serotonin and cancer:what is the link?" 15 : 62-77, 2015

9 Anderson KE, "Pharmacology of lower urinary tract smooth muscles and penile erectile tissues" 45 : 253-308, 1993

10 Corsi M, "Pharmacological analysis of 5-hydroxytryptamine effects on electrically stimulated human isolated urinary bladder" 104 : 719-725, 1991

11 Farthing MJ, "Pharmacokinetics of naftopidil, a novel anti-hypertensive drug, in patients with hepatic dysfunction" 70 : 363-366, 1994

12 Reimann IW, "Pharmacokinetics of ketanserin in man" 25 : 73-76, 1983

13 Candura SM, "Neural 5-HT4 receptors in the human isolated detrusor muscle: effects of indole, benzimidazolone and substituted benzamide agonists and antagonists" 118 : 1965-1970, 1996

14 Takei R, "Naftopidil, a novel alpha1-adrenoceptor antagonist, displays selective inhibition of canine prostatic pressure and high affinity binding to cloned human alpha1-adrenoceptors" 79 : 447-454, 1999

15 Sakai T, "Naftopidil inhibits 5-hydroxytryptamine-induced bladder contraction in rats" 700 : 194-200, 2013

16 Hannon J, "Molecular biology of 5-HT receptors" 195 : 198-213, 2008

17 de Groat WC, "Modulation of voiding and storage reflexes by activation of alpha1-adrenoceptors" 36 (36): 68-73, 1999

18 O’Connor JC, "Lipopolysaccharide-induced depressive-like behavior is mediated by indoleamine 2,3-dioxygenase activation in mice" 14 : 511-522, 2009

19 Ismaiel AM, "Ketanserin analogues : the effect of structural modification on 5-HT2 serotonin receptor binding" 38 : 1196-1202, 1995

20 Hoyer D, "International Union of Pharmacology classification of receptors for 5-hydroxytryptamine(Serotonin)" 46 : 157-203, 1994

21 Moreau M, "Inoculation of Bacillus Calmette-Guerin to mice induces an acute episode of sickness behavior followed by chronic depressive-like behavior" 22 : 1087-1095, 2008

22 Klarskov P, "Influence of serotonin on lower urinary tract smooth muscle in vitro" 58 : 507-513, 1986

23 Imamura T, "Expression of 5-hydroxytryptamine receptors in human urinary bladders with benign prostatic hyperplasia" 32 (32): 29-37, 2015

24 Feldman PD, "Effects of serotonin-1 and serotonin-2 receptor agonists on neuronal activity in the nucleus tractus solitarius" 56 : 119-124, 1995

25 Sathi ZS, "Different affinities of native alpha1B-adrenoceptors for ketanserin between intact tissue segments and membrane preparations" 584 : 222-228, 2008

26 Gotoh M, "Comparison of tamsulosin and naftopidil for efficacy and safety in the treatment of benign prostatic hyperplasia : a randomized controlled trial" 96 : 581-586, 2005

27 Tonini M, "Characterization of the 5-HT receptor potentiating neuromuscular cholinergic transmission in strips of human isolated detrusor muscle" 113 : 1-2, 1994

28 D’Agostino G, "Characterization of prejunctional serotonin receptors modulating [3H]acetylcholine release in the human detrusor" 316 : 129-135, 2006

29 Israilova M, "Binding and functional affinity of sarpogrelate, its metabolite m-1 and ketanserin for human recombinant alpha-1-adrenoceptor subtypes" 65 : 69-73, 2002

30 Moreau M, "Bacille Calmette-Guérin inoculation induces chronic activation of peripheral and brain indoleamine 2,3-dioxygenase in mice" 192 : 537-544, 2005

31 Campos-Bedolla P, "Alpha-methyl-5-HT, a 5-HT2 receptor agonist, stimulates beta2-adrenoceptors in guinea pig airway smooth muscle" 54 : 468-473, 2006

32 Baxter G, "5-HT2 receptor subtypes:a family re-united?" 16 : 105-110, 1995

33 Ismaiel AM, "5-HT1and 5-HT2 binding profiles of the serotonergic agents alpha-methylserotonin and 2-methylserotonin" 33 : 755-758, 1990

34 Borbe HO, "5-HT1A-agonistic properties of naftopidil, a novel antihypertensive drug" 205 : 105-107, 1991

35 Sorbi C, "1,3-Dioxolane-based ligands as rigid analogues of naftopidil: structure-affinity/activity relationships at alpha1 and 5-HT1A receptors" 4 : 393-399, 2009